Advertisement

Journal of Pharmaceutical Investigation

, Volume 49, Issue 1, pp 105–114 | Cite as

Charge reduction: an efficient strategy to reduce toxicity and increase the transfection efficiency of high molecular weight polyethylenimine

  • Mehdi Rezaee
  • Leila Gholami
  • Mojtaba Seddighi Gildeh
  • Mohammad Ramezani
  • Reza Kazemi Oskuee
Original Article
  • 71 Downloads

Abstract

With high potency in treatment of various diseases, gene therapy is mainly hindered by lack of safe and efficient gene delivery vectors. The current study was aimed to develop an efficient non-viral vector with adequate cytotoxicity. To this end, alkylcarboxylate chains (6C, 10C, 16C) were exploited to ameliorate the characteristics of PEI 750 kDa. Briefly, alkylcarboxylate chains with three different lengths (6C, 10C, 16C) were chemically grafted to the primary amine groups of PEI 750 kDa in three percentages (10, 50, and 100%). After evaluating the physicochemical properties of prepared vectors including surface charge, size, buffering capacity, and DNA condensing, their transfection efficiency and cytotoxicity were investigated in Neuro2A cells. The polyplexes size were 158.9–264.5 nm and their zeta potentials were 14–30 mV, while their buffering capacity and DNA condensing were not significantly decreased. The highest transfection efficiency in term of C/P ratio was observed in PEI750-10C-68%, PEI750-10C-7%, and PEI750-6C-7% at C/P ratios of 2, 4, and 6, respectively. Altogether, the decanoylcarboxylate-modified PEI with medium grafting percentages showed promising results as gene delivery vector. To sum up, the modification of high molecular weight PEIs by alkylcarboxylate chains is an efficient approach for development of more efficient non-viral vectors.

Keywords

Alkylcarboxylate chains Gene delivery Non-viral vectors Polyethylenimine Polyplexes 

Notes

Acknowledgements

This study was supported by Mashhad University of Medical Sciences (MUMS), Mashhad, Iran.

Compliance with ethical standards

Conflict of interest

All authors (M. Rezaee, L. Gholami, M. Seddighi Gildeh, M. Ramezani and R. Kazemi Oskuee) declare that they have no conflict of interest.

Research involving human and animal participants

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

  1. Akinc A, Thomas M, Klibanov AM, Langer R (2005) Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 7:657–663CrossRefGoogle Scholar
  2. Chen B, Le W, Wang Y, Li Z, Wang D, Ren L, Lin L, Cui S, Hu JJ, Hu Y et al (2016) Targeting negative surface charges of cancer cells by multifunctional nanoprobes. Theranostics 6:1887–1898CrossRefGoogle Scholar
  3. Creusat G, Rinaldi A-S, Weiss E, Elbaghdadi R, Remy J-S, Mulherkar R, Zuber G (2010) Proton sponge trick for pH-sensitive disassembly of polyethylenimine-based siRNA delivery systems. Bioconj Chem 21:994–1002CrossRefGoogle Scholar
  4. Dammeijer F, Lievense LA, Veerman GM, Hoogsteden HC, Hegmans JP, Arends LR, Aerts JG (2016) The efficacy of tumor vaccines and cellular immunotherapies in non-small cell lung cancer: a systematic review and meta-analysis. J Clin Oncol 34(26):3204–3212CrossRefGoogle Scholar
  5. Dehshahri A, Oskuee RK, Shier WT, Hatefi A, Ramezani M (2009) Gene transfer efficiency of high primary amine content, hydrophobic, alkyl-oligoamine derivatives of polyethylenimine. Biomaterials 30:4187–4194CrossRefGoogle Scholar
  6. Dehshahri A, Oskuee RK, Ramezani M (2012a) Plasmid DNA delivery into hepatocytes using a multifunctional nanocarrier based on sugarconjugated polyethylenimine. Gene Ther Mol Biol 14:62–71Google Scholar
  7. Dehshahri A, Oskuee RK, Shier WT, Ramezani M (2012b) β-Galactosylated alkyl-oligoamine derivatives of polyethylenimine enhanced pDNA delivery into hepatic cells with reduced toxicity. Curr Nanosci 8:548–555CrossRefGoogle Scholar
  8. Dehshahri A, Sadeghpour H, Oskuee RK, Fadaei M, Sabahi Z, Alhashemi SH, Mohazabieh E (2014) Interleukin-12 plasmid DNA delivery using L-thyroxine-conjugated polyethylenimine nanocarriers. ‎J Nanopart Res 16:2423CrossRefGoogle Scholar
  9. Doody AM, Korley JN, Dang KP, Zawaneh PN, Putnam D (2006) Characterizing the structure/function parameter space of hydrocarbon-conjugated branched polyethylenimine for DNA delivery in vitro. J Control Release 116:227–237CrossRefGoogle Scholar
  10. Erbacher P, Bettinger T, Brion E, Coll JL, Plank C, Behr JP, Remy JS (2004) Genuine DNA/polyethylenimine (PEI) complexes improve transfection properties and cell survival. J Drug Target 12:223–236CrossRefGoogle Scholar
  11. Fioretti D, Iurescia S, Fazio VM, Rinaldi M (2010) DNA vaccines: developing new strategies against cancer. Biomed Res IntGoogle Scholar
  12. Kazemi Oskuee R, Zakeri V, Gholami L, Malaekeh-Nikouei B (2015) Preparation, characterization and transfection efficiency of nanoparticles composed of alkane-modified polyallylamine. Nanomed J 2:111–120Google Scholar
  13. Komin A, Russell L, Hristova K, Searson P (2017) Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges. Adv Drug Del Rev 110–111:52–64CrossRefGoogle Scholar
  14. Ma K, Hu M, Qi Y, Qiu L, Jin Y, Yu J, Li B (2009) Structure–transfection activity relationships with glucocorticoid–polyethyl-enimine conjugate nuclear gene delivery systems. Biomaterials 30:3780–3789CrossRefGoogle Scholar
  15. Malaekeh-Nikouei B, Rezaee M, Gholami L, Behzad M, Mohajeri M, Kazemi Oskuee R (2017) Dexamethasone conjugated polyallylamine: Synthesis, characterization, and in vitro transfection and cytotoxicity. J Drug Deliv Sci Technol 40:172–179CrossRefGoogle Scholar
  16. Navarro SA, Carrillo E, Griñán-Lisón C, Martín A, Perán M, Marchal JA, Boulaiz H (2016) Cancer suicide gene therapy: a patent review. Expert Opin Ther Pat 26:1095–1104CrossRefGoogle Scholar
  17. Nguyen J, Xie X, Neu M, Dumitrascu R, Reul R, Sitterberg J, Bakowsky U, Schermuly R, Fink L, Schmehl T et al (2008) Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs. J Gene Med 10:1236–1246CrossRefGoogle Scholar
  18. Nimesh S, Aggarwal A, Kumar P, Singh Y, Gupta KC, Chandra R (2007) Influence of acyl chain length on transfection mediated by acylated PEI nanoparticles. Int J Pharm 337:265–274CrossRefGoogle Scholar
  19. Oskuee RK, Dehshahri A, Shier WT, Ramezani M (2009) Alkylcarboxylate grafting to polyethylenimine: a simple approach to producing a DNA nanocarrier with low toxicity. J Gene Med 11:921–932CrossRefGoogle Scholar
  20. Oskuee RK, Philipp A, Dehshahri A, Wagner E, Ramezani M (2010) The impact of carboxyalkylation of branched polyethylenimine on effectiveness in small interfering RNA delivery. J Gene Med 12:729–738CrossRefGoogle Scholar
  21. Pack DW, Hoffman AS, Pun S, Stayton PS (2005) Design and development of polymers for gene delivery. Nat Rev Drug Discovery 4:581–593CrossRefGoogle Scholar
  22. Patnaik S, Gupta KC (2013) Novel polyethylenimine-derived nanoparticles for in vivo gene delivery. Expert Opin Drug Deliv 10:215–228CrossRefGoogle Scholar
  23. Paul-Smith MC, Bell RV, Alton WE, Alton EW, Griesenbach U (2016) Gene therapy for cystic fibrosis: recent progress and current aims. Expert Opin Orphan Drugs Drugs 4:649–658CrossRefGoogle Scholar
  24. Penacho N, Simões S, de Lima MCP (2009) Polyethylenimine of various molecular weights as adjuvant for transfection mediated by cationic liposomes. Mol Membr Biol 26:249–263CrossRefGoogle Scholar
  25. Pezzoli D, Tsekoura EK, Remant Bahadur KC, Candiani G, Mantovani D, Uludağ H (2017) Hydrophobe-substituted bPEI derivatives: boosting transfection on primary vascular cells. Sci China Mater 60:529–542CrossRefGoogle Scholar
  26. Rehman Z, Zuhorn IS, Hoekstra D (2013) How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances. J Control Release 166:46–56CrossRefGoogle Scholar
  27. Rezaee M, Oskuee RK, Nassirli H, Malaekeh-Nikouei B (2016) Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems. J Control Release 236:1–14CrossRefGoogle Scholar
  28. Sarisozen C, Pan J, Dutta I, Torchilin VP (2017) Polymers in the co-delivery of siRNA and anticancer drugs to treat multidrug-resistant tumors. J Pharm Investig 47:37–49CrossRefGoogle Scholar
  29. Shen ZL, Xia YQ, Yang QS, Tian WD, Chen K, Ma YQ (2017) Polymer–nucleic acid interactions. Top Curr Chem 375(2):44CrossRefGoogle Scholar
  30. Snyder SL, Sobocinski PZ (1975) An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem 64:284–288CrossRefGoogle Scholar
  31. Teo PY, Yang C, Hedrick JL, Engler AC, Coady DJ, Ghaem-Maghami S, George AJ, Yang YY (2013) Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection. Biomaterials 34:7971–7979CrossRefGoogle Scholar
  32. Thi EP, Lee AC, Geisbert JB, Ursic-Bedoya R, Agans KN, Robbins M, Deer DJ, Fenton KA, Kondratowicz AS, MacLachlan I (2016) Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA. Nat Microbiol 1:16142CrossRefGoogle Scholar
  33. Thomas T, Tajmir-Riahi H, Thomas T (2016) Polyamine–DNA interactions and development of gene delivery vehicles. Amino Acids 48:2423–2431CrossRefGoogle Scholar
  34. Verma IM, Somia N (1997) Gene therapy-promises, problems and prospects. Nature 389:239–242CrossRefGoogle Scholar
  35. von Harpe A, Petersen H, Li Y, Kissel T (2000) Characterization of commercially available and synthesized polyethylenimines for gene delivery. J Controlled Release 69:309–322CrossRefGoogle Scholar
  36. Yang Z, Jiang Z, Cao Z, Zhang C, Gao D, Luo X, Zhang X, Luo H, Jiang Q, Liu J (2014) Multifunctional non-viral gene vectors with enhanced stability, improved cellular and nuclear uptake capability, and increased transfection efficiency. Nanoscale 6:10193–10206CrossRefGoogle Scholar
  37. Zheng M, Zhong YA, Meng FH, Peng R, Zhong ZY (2011) Lipoic acid modified low molecular weight polyethylenimine mediates nontoxic and highly potent in vitro gene transfection. Mol Pharm 8:2434–2443CrossRefGoogle Scholar

Copyright information

© The Korean Society of Pharmaceutical Sciences and Technology 2018

Authors and Affiliations

  • Mehdi Rezaee
    • 1
    • 2
  • Leila Gholami
    • 3
  • Mojtaba Seddighi Gildeh
    • 4
  • Mohammad Ramezani
    • 4
  • Reza Kazemi Oskuee
    • 1
    • 5
  1. 1.Department of Medical Biotechnology, Faculty of MedicineMashhad University of Medical SciencesMashhadIran
  2. 2.Student Research CommitteeMashhad University of Medical SciencesMashhadIran
  3. 3.Department of Modern Sciences and Technologies, Faculty of MedicineMashhad University of Medical SciencesMashhadIran
  4. 4.Pharmaceutical Research CenterPharmaceutical Technology Institute, Mashhad University of Medical SciencesMashhadIran
  5. 5.Nanotechnology Research CenterMashhad University of Medical SciencesMashhadIran

Personalised recommendations